Conference Coverage

Simplified HCT-CI better predicts outcomes in young patients


 

REPORTING FROM ALF 2018


“We sought to develop a modified HCT-CI that would be more practical and efficient in predicting outcomes of adolescent and young adult patients,” he wrote.

Data were collected on 15 comorbidities included in the original HCT-CI study, as well as the psychosocial risk factors. The relationship between multiple variables and the incidence of nonrelapse mortality was investigated via the Fine and Gray competing risk model with adjustments for patient- and transplant-specific factors.

[embed:render:related:node:101832]

A few things were “looked at differently,” he said, explaining, for example, that multiple cardiovascular risk factors were combined into one since they are rare in younger patients.

The study demonstrated that an index including only a few comorbidities important in adolescents and young adults is more predictive in these younger patients vs. adults, suggesting that a simpler model is more practical and useful, Dr. Friend said.

Recommended Reading

Xenon imaging could detect lung involvement after HSCT
MDedge Hematology and Oncology
Low microbiota diversity linked to poor survival after transplant
MDedge Hematology and Oncology
Ibrutinib preserves immune memory while fighting cGVHD
MDedge Hematology and Oncology
Posttransplant cyclophosphamide helped reduce GVHD rates
MDedge Hematology and Oncology
High engraftment with new umbilical transplant technique
MDedge Hematology and Oncology
Study: Stick with TMP-SMX for posttransplant PJP prophylaxis
MDedge Hematology and Oncology
Coming soon: CAR T-cell approvals in multiple myeloma
MDedge Hematology and Oncology
Reduced intensity conditioning doesn’t protect fertility
MDedge Hematology and Oncology
Study shows value of pretransplant assessment of function, endurance
MDedge Hematology and Oncology
Genetic markers may help predict allogeneic SCT outcomes
MDedge Hematology and Oncology